🔎 Trials Near Me

Akèy › Sipwa › Tennessee › Nashville

Etid klinik pou Sipwa nan Nashville, TN

10 etid pou Sipwa ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 2
  • Clinical Research Associates - Nashville /ID# 282161, Nashville
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07752979

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Ap rekriteFaz 2
  • AMR Clinical, Nashville
Laj 18 a 75 · Tout sèks · Mizajou Sep 28, 2026 · NCT07837973

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Ap rekriteFaz 3
  • Clinical Research Associates Inc, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07794579

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Ap rekriteFaz 3
  • Vanderbilt Health One Hundred Oaks, Nashville
Laj 6 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT06672549

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Ap rekriteFaz 3
  • Research Site, Franklin · 17 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3
  • AMR Clinical, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • Quality Medical Research, Nashville
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589608

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3
  • Clinical Research Associates, Nashville
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Ap rekriteFaz 3Volontè an sante akeyi
  • ACCOMPLISH-2 Research Site, Nashville
Laj 18 a 79 · Tout sèks · Mizajou Sep 11, 2026 · NCT07654374

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • Quality Medical Research, Nashville
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT06143956

Etid Sipwa nan lòt vil

Lòt etid nan Nashville

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.